Peter Borghgraef

3.3k total citations
43 papers, 2.7k citations indexed

About

Peter Borghgraef is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Borghgraef has authored 43 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 19 papers in Molecular Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Borghgraef's work include Alzheimer's disease research and treatments (32 papers), Neuroscience and Neuropharmacology Research (13 papers) and Prion Diseases and Protein Misfolding (8 papers). Peter Borghgraef is often cited by papers focused on Alzheimer's disease research and treatments (32 papers), Neuroscience and Neuropharmacology Research (13 papers) and Prion Diseases and Protein Misfolding (8 papers). Peter Borghgraef collaborates with scholars based in Belgium, United States and France. Peter Borghgraef's co-authors include Fred Van Leuven, Ilse Dewachter, Herman Devijver, Dick Terwel, F. Van Leuven, S. Croes, David Muyllaert, Tomasz Jaworski, F. Van Leuven and J. Snauwaert and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter Borghgraef

43 papers receiving 2.7k citations

Peers

Countries citing papers authored by Peter Borghgraef

Since Specialization

Citations

This map shows the geographic impact of Peter Borghgraef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Borghgraef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Borghgraef more than expected).

Fields of papers citing papers by Peter Borghgraef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Borghgraef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Borghgraef. The network helps show where Peter Borghgraef may publish in the future.

Co-authorship network of co-authors of Peter Borghgraef

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Borghgraef. A scholar is included among the top collaborators of Peter Borghgraef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Borghgraef. Peter Borghgraef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GSK-3 alpha/beta kinases and amyloid production in vivo 2011 ·Nature ·Tomasz Jaworski, Ilse Dewachter, Benoit Lechat, Maarten Gees, (unknown), David Demedts, Peter Borghgraef, Herman Devijver, (unknown), Satish Patel, James R. Woodgett, (unknown)	4
2	Age-Related Impairment of Ultrasonic Vocalization in Tau.P301L Mice: Possible Implication for Progressive Language Disorders 2011 ·PLoS ONE ·Clément Menuet, Yves Cazals, Christian Gestreau, Peter Borghgraef, (unknown), Mathias Dutschmann, Fred Van Leuven, Gérard Hilaire	32
3	Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: Possible implications for tauopathies and Alzheimer's disease 2011 ·Respiratory Physiology & Neurobiology ·Clément Menuet, Peter Borghgraef, Valéry Matarazzo, (unknown), (unknown), Nicolas Voituron, Christian Gestreau, Mathias Dutschmann, Fred Van Leuven, Gérard Hilaire	30
4	Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice 2011 ·Journal of Neuroscience ·(unknown), Hervé Maurin, David Demedts, Herman Devijver, Peter Borghgraef, Fred Van Leuven	45
5	GSK3ß, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9 2009 ·Neurobiology of Disease ·Ilse Dewachter, Laurence Ris, Tomasz Jaworski, (unknown), (unknown), Peter Borghgraef, (unknown), Emile Godaux, F. Van Leuven	82
6	AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice 2009 ·PLoS ONE ·Tomasz Jaworski, Ilse Dewachter, Benoit Lechat, S. Croes, (unknown), David Demedts, Peter Borghgraef, Herman Devijver, Robert K. Filipkowski, Leszek Kaczmarek, Sebastian Kügler, Fred Van Leuven	69
7	Neurodegeneration and Neuroinflammation in cdk5/p25-Inducible Mice 2008 ·American Journal Of Pathology ·David Muyllaert, Dick Terwel, (unknown), Kristina Sennvik, Peter Borghgraef, Herman Devijver, Ilse Dewachter, Fred Van Leuven	46
8	Glycogen synthase kinase‐3β, or a link between amyloid and tau pathology? 2008 ·Genes Brain & Behavior ·David Muyllaert, (unknown), Tomasz Jaworski, Peter Borghgraef, Herman Devijver, S. Croes, Ilse Dewachter, F. Van Leuven	110
9	Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic Mice 2008 ·American Journal Of Pathology ·Dick Terwel, David Muyllaert, Ilse Dewachter, Peter Borghgraef, S. Croes, Herman Devijver, F. Van Leuven	250
10	11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid β in Alzheimer's disease 2008 ·European Journal of Medicinal Chemistry ·Kim Serdons, (unknown), Dominique Vanderghinste, Peter Borghgraef, (unknown), F. Van Leuven, Hank F. Kung, Guy Bormans, Alfons Verbruggen	26
11	Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1 2007 ·Neurobiology of Aging ·Ilse Dewachter, (unknown), S. Croes, Peter Borghgraef, Herman Devijver, Thomas Voets, Bernd Nilius, Emile Godaux, F. Van Leuven	41
12	Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice 2007 ·Neurobiology of Aging ·Ilse Dewachter, Robert K. Filipkowski, (unknown), Laurence Ris, Jacques Neyton, S. Croes, Dick Terwel, (unknown), Herman Devijver, Peter Borghgraef, Emile Godaux, Leszek Kaczmarek, Jochen Herms, F. Van Leuven	89
13	Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ 2006 ·Proceedings of the National Academy of Sciences ·Magdalena Sastre, Ilse Dewachter, Steffen Roßner, Nenad Bogdanović, Evan D. Rosen, Peter Borghgraef, Bernd O. Evert, Lucia Dumitrescu‐Ozimek, Dietmar Rudolf Thal, Gary E. Landreth, Jochen Walter, Thomas Klockgether, Fred Van Leuven, Michael T. Heneka	321
14	Neuronal or Glial Expression of Human Apolipoprotein E4 Affects Parenchymal and Vascular Amyloid Pathology Differentially in Different Brain Regions of Double- and Triple-Transgenic Mice 2006 ·American Journal Of Pathology ·(unknown), David Muyllaert, Peter Borghgraef, (unknown), Herman Devijver, Ingrid Van der Auwera, Stefaan Wera, Ilse Dewachter, Fred Van Leuven	31
15	Transgenic mouse models for Alzheimer's disease: the role of GSK-3β in combined amyloid and tau-pathology 2006 ·Revue Neurologique ·David Muyllaert, Dick Terwel, Peter Borghgraef, Herman Devijver, Ilse Dewachter, F. Van Leuven	36
16	Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy 2006 ·Journal of Neuroscience ·Karin Boekhoorn, Dick Terwel, (unknown), Peter Borghgraef, Olof Wiegert, G.J.A. Ramakers, (unknown), Harm J. Krugers, Takami Tomiyama, Hiroshi Mori, Marian Joëls, Fred Van Leuven, Paul J. Lucassen	137
17	Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease 2005 ·Magnetic Resonance in Medicine ·Greetje Vanhoutte, Ilse Dewachter, Peter Borghgraef, F. Van Leuven, Annemie Van der Linden	119
18	Transgenic Mouse Models for APP Processing and Alzheimer’s Disease: Early and Late Defects 2005 ·Sub-cellular biochemistry ·(unknown), Ilse Dewachter, Peter Borghgraef, Fred Van Leuven	25
19	Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models 2004 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Alain Boom, Roland Pochet, Michèle Authelet, Laurent Pradier, Peter Borghgraef, Fred Van Leuven, Claus W. Heizmann, Jean‐Pierre Brion	67
20	β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Increases Amyloid Deposition in Brain Parenchyma but Reduces Cerebrovascular Amyloid Angiopathy in Aging BACE × APP[V717I] Double-Transgenic Mice 2004 ·American Journal Of Pathology ·Michael Willem, Ilse Dewachter, Neil Smyth, (unknown), Peter Borghgraef, Christian Haass, Fred Van Leuven	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact